These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9514605)

  • 21. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
    Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
    J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.
    Kishimoto S; Miyazawa K; Terakawa Y; Ashikari H; Ohtani A; Fukushima S; Takeuchi Y
    Jpn J Cancer Res; 2000 Dec; 91(12):1326-32. PubMed ID: 11123433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenotoxic properties of chlorophyll b against cisplatin-induced DNA damage and its relationship with distribution of platinum and magnesium in vivo.
    Serpeloni JM; Batista BL; Angeli JP; Barcelos GR; Bianchi Mde L; Barbosa F; Antunes LM
    J Toxicol Environ Health A; 2013; 76(6):345-53. PubMed ID: 23557233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity.
    Li J; Sun K; Ni L; Wang X; Wang D; Zhang J
    Toxicol Appl Pharmacol; 2012 Feb; 258(3):376-83. PubMed ID: 22172630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.
    Herman TS; Teicher BA; Chan V; Collins LS; Kaufmann ME; Loh C
    Cancer Res; 1988 May; 48(9):2335-41. PubMed ID: 3356001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity.
    Mizumura Y; Matsumura Y; Hamaguchi T; Nishiyama N; Kataoka K; Kawaguchi T; Hrushesky WJ; Moriyasu F; Kakizoe T
    Jpn J Cancer Res; 2001 Mar; 92(3):328-36. PubMed ID: 11267944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding kinetics of tetrachloro-1,2-diaminocyclohexaneplatinum (IV) (tetraplatin) and cis-diamminedichloroplatinum (II) at 37 degrees C with human plasma proteins and with bovine serum albumin. Does aquation precede protein binding?
    LeRoy AF; Thompson WC
    J Natl Cancer Inst; 1989 Mar; 81(6):427-36. PubMed ID: 2918550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute toxicity study of cisplatin loaded long-circulating and pH-sensitive liposomes administered in mice.
    Leite EA; Lana AM; Junior AD; Coelho LG; De Oliveira MC
    J Biomed Nanotechnol; 2012 Apr; 8(2):229-39. PubMed ID: 22515074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA; Saad SY
    Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of cisplatin chronotoxicity related to reduced glutathione in mice.
    Boughattas NA; Li XM; Filipski J; Lemaigre G; Filipski E; Bouzouita K; Belhadj O; Lévi F
    Hum Exp Toxicol; 1996 Jul; 15(7):563-72. PubMed ID: 8818709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
    Wang GW; Guo W; Tang XD; Peng CL; Zhao H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of protein thiols in inhibition of sodium-coupled glucose uptake by cisplatin in renal brush-border membrane vesicles.
    Potdevin S; Courjault-Gautier F; Du Sorbier BM; Ripoche P; Toutain HJ
    J Pharmacol Exp Ther; 1998 Jan; 284(1):142-50. PubMed ID: 9435172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance.
    Okada T; El-Mehasseb IM; Kodaka M; Tomohiro T; Okamoto K; Okuno H
    J Med Chem; 2001 Dec; 44(26):4661-7. PubMed ID: 11741483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preventive effect of urinastatin on cisplatin induced nephrotoxicity in rabbits].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):328-32. PubMed ID: 2567322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of two-route chemotherapy using cis-diamminedichloroplatinum(II) and its antidote, sodium thiosulfate, in combination with angiotensin II in a rat limb tumor.
    Kuroiwa T; Aoki K; Taniguchi S; Hasuda K; Baba T
    Cancer Res; 1987 Jul; 47(14):3618-23. PubMed ID: 3594429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and antitumor activity of a new platinum compound, cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1, 3- dioxolane]platinum(II), as determined by ex vivo pharmacodynamics.
    Kim DK; Kim HT; Tai JH; Cho YB; Kim TS; Kim KH; Park JG; Hong WS
    Cancer Chemother Pharmacol; 1995; 37(1-2):1-6. PubMed ID: 7497577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.